Epidemiologic Aspects of Alopecia Areata in Nangarhar Province, Afghanistan: A Retrospective Study (2023-2024)

##plugins.themes.academic_pro.article.main##

Rohullah Asady
Mohammad Qais Nabizada
Hayatullah Ahmadzai

Abstract

Alopecia areata is a common, chronic, inflammatory disease causing non-scarring hair loss. This autoimmune disorder, mediated by T-cells, arises from inadequate major histocompatibility complex (MHC-I) molecule expression on hair follicle surfaces due to genetic defects, triggering antibody production. Hair follicles typically retain reactivation capacity, with most cases improving within a year. Clinically, smooth, shiny, circular patches of hair loss appear, often with broken hairs at the edges. Although etiology remains unclear, genetic predisposition, immune dysfunction, and environmental factors are implicated. This retrospective cross-sectional study at Nangarhar University Teaching Hospital analyzed 22,650 dermatology patients (2023–2024). Among 241(1.1%) alopecia cases, 81 had alopecia areata. Most (92.6%) exhibited mild (patchy) forms, 72.8% were male, and the majority (87.6%) were aged 1–30 years. Rural residents constituted 64.2%. Comparisons with global studies showed similar demographics, though no cases under one year were observed, contrasting with Saudi Arabian reports. Findings highlight a male predominance, mild clinical presentations, and middle-aged rural residents as the most affected.

Keywords

Alopecia, Areata, Epidemiologic, aspects, Nangarhar, University, Teaching, Hospital

##plugins.themes.academic_pro.article.details##

Author Biographies

Rohullah Asady, Nangarhar University

Department of Dermatology, Faculty of Medicine, Nangarhar University, Nangarhar, Afghanistan

Mohammad Qais Nabizada, Nangarhar University

Department of Physiology,Faculty of Medicine,Nangarhar University, Nangarhar, Afghanistan

Hayatullah Ahmadzai, Nangarhar University

Department of internal medicine, Faculty of Medicine, Nangarhar University, Nangarhar, Afghanistan

How to Cite
Asady, R., Nabizada, M. Q., & Ahmadzai, H. (2025). Epidemiologic Aspects of Alopecia Areata in Nangarhar Province, Afghanistan: A Retrospective Study (2023-2024). Nangarhar University International Journal of Biosciences, 3(04), 54–58. https://doi.org/10.70436/nuijb.v3i04.361

References

  1. Alshahrani, A. A., Al-Tuwaijri, R., Abuoliat, Z. A., Alyabsi, M., AlJasser, M. I., & Alkhodair, R. (2020). Prevalence and clinical characteristics of alopecia areata at a tertiary care center in Saudi Arabia. Dermatology research and practice, 2020(1), 7194270.
  2. Aranishi, T., Ito, T., Fukuyama, M., Isaka, Y., Mackie, D. S., King‐Concialdi, K., Senglaub, S. S., Jaffe, D. H., Shimomura, Y., & Ohyama, M. (2023). Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample. The Journal of Dermatology, 50(1), 26-36.
  3. Benigno, M., Anastassopoulos, K. P., Mostaghimi, A., Udall, M., Daniel, S. R., Cappelleri, J. C., Chander, P., Wahl, P. M., Lapthorn, J., & Kauffman, L. (2020). A large cross-sectional survey study of the prevalence of alopecia areata in the United States. Clinical, cosmetic and investigational dermatology, 259-266.
  4. Chanprapaph, K., Mahasaksiri, T., Kositkuljorn, C., Leerunyakul, K., & Suchonwanit, P. (2021). Prevalence and risk factors associated with the occurrence of autoimmune diseases in patients with alopecia areata. Journal of Inflammation Research, 4881-4891.
  5. Colón, E. A., Popkin, M. K., Callies, A. L., Dessert, N. J., & Hordinsky, M. K. (1991). Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Comprehensive psychiatry, 32(3), 245-251.
  6. Farajzadeh, S., Rahnama, Z., Esfandiarpour, I., Tardast, A., Hasheminasab, S., Damavandi, F. D., Pourdamghan, N., Mohamadi, S., Reghabatpoor, L., & Fathi, O. (2013). Clinical and demographic profile of childhood alopecia areata in Iran. Journal of pakistan association of dermatologists, 23(1), 20-27.
  7. Korta, D. Z., Christiano, A. M., Bergfeld, W., Duvic, M., Ellison, A., Fu, J., Harris, J. E., Hordinsky, M. K., King, B., & Kranz, D. (2018). Alopecia areata is a medical disease. Journal of the American Academy of Dermatology, 78(4), 832-834.
  8. Lee, H. H., Gwillim, E., Patel, K. R., Hua, T., Rastogi, S., Ibler, E., & Silverberg, J. I. (2020). Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis. Journal of the American Academy of Dermatology, 82(3), 675-682.
  9. McKenzie, P. L., Maltenfort, M., Bruckner, A. L., Gupta, D., Harfmann, K. L., Hyde, P., Forrest, C. B., & Castelo-Soccio, L. (2022). Evaluation of the prevalence and incidence of pediatric alopecia areata using electronic health record data. JAMA dermatology, 158(5), 547-551.
  10. Mostaghimi, A., Gao, W., Ray, M., Bartolome, L., Wang, T., Carley, C., Done, N., & Swallow, E. (2023). Trends in prevalence and incidence of alopecia areata, alopecia totalis, and alopecia universalis among adults and children in a US employer-sponsored insured population. JAMA dermatology, 159(4), 411-418.
  11. Sehgal, V. N., Srivastava, G., Aggarwal, A., Sethi, G., & Adhikari, T. (2007). Alopecia areata in the Indian subcontinent. SKINmed: Dermatology for the Clinician, 6(2), 63-69.
  12. Shrestha, P., Shrestha, M., & Gurung, S. (2023). Association between Alopecia Areata and Thyroid Dysfunction in Western Nepal. Nepal Journal Of Medical Sciences, 8(1).
  13. Tosti, A., Morelli, R., Bardazzi, F., & Peluso, A. M. (1994). Prevalence of nail abnormalities in children with alopecia areata. Pediatric dermatology, 11(2), 112-115.